Fleur L. Meulmeester, Camiel J. M. Marijnissen, Jacob K. Sont. Letter to the editor regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes”. // International Forum of Allergy and Rhinology. – 2026. – DOI: 10.1002/alr.70291. – URL: https://onlinelibrary.wiley.com/doi/10.1002/alr.70291?af=R
Fleur L. Meulmeester, Camiel J. M. Marijnissen, & Jacob K. Sont (2026). Letter to the editor regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes”. International Forum of Allergy and Rhinology. https://doi.org/10.1002/alr.70291
Fleur L. Meulmeester, et al. “Letter to the editor regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes”.” International Forum of Allergy and Rhinology, 2026. doi:10.1002/alr.70291.
@article{Meulmeester2026,
title = {Letter to the editor regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes”},
author = {Meulmeester, Fleur L. and Marijnissen, Camiel J. M. and Sont, Jacob K.},
journal = {International Forum of Allergy and Rhinology},
year = {2026},
doi = {10.1002/alr.70291},
url = {https://onlinelibrary.wiley.com/doi/10.1002/alr.70291?af=R}
}